FDA Inspection 1006244 — Central Pennsylvania Blood Bank
The FDA completed an inspection of Central Pennsylvania Blood Bank on Mar 23, 2017 in Hanover, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 23, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Hanover, PA (United States)